Trial Profile
A retrospective multicenter study of Bendamustine in patients with refractory or relapsed T cell lymphomas.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications T-cell lymphoma
- Focus Therapeutic Use
- 21 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology